A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection
A. E. Sikora, C. Gomez, A. Le Van, B. I. Baarda, s. Darnell, F. G. Martinez, R. A. Zielke, J. A. Bonventre, A. E. Jerse
This study evaluates a gonorrhea vaccine candidate, rMetQ-CpG, showing it induces protective immune responses and accelerates bacterial clearance in a murine model.
bioRxiv · Jun 19, 2020Microbiology